Free Trial
OTCMKTS:XSNX

NovAccess Global (XSNX) Stock Price, News & Analysis

NovAccess Global logo
$0.0090 0.00 (0.00%)
(As of 11/22/2024 ET)

About NovAccess Global Stock (OTCMKTS:XSNX)

Key Stats

Today's Range
$0.0090
$0.0090
50-Day Range
$0.0040
$0.0140
52-Week Range
$0.00
$0.05
Volume
20,018 shs
Average Volume
8,380 shs
Market Capitalization
$401,400.00
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

NovAccess Global Inc., a biopharmaceutical company, develops novel immunotherapies to treat brain tumor patients in the United States. It specializes in cutting-edge research related to utilizing a patient's immune system to attack the cancer. The company was incorporated in 1997 and is headquartered in Chagrin Falls, Ohio.

Receive XSNX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for NovAccess Global and its competitors with MarketBeat's FREE daily newsletter.

XSNX Stock News Headlines

Global wage calculator: Compare your salary
NovAccess Global Inc.
Trump won. Buy this coin now.
Juan Villaverde called the top and bottom of every crypto bull market since 2012. He believes Bitcoin will go to $150,000 — or more. But there’s one coin he thinks could go even higher.
NovAccess Global Inc. (XSNX)
See More Headlines

XSNX Stock Analysis - Frequently Asked Questions

NovAccess Global's stock was trading at $0.0201 on January 1st, 2024. Since then, XSNX shares have decreased by 55.2% and is now trading at $0.0090.
View the best growth stocks for 2024 here
.

Shares of XSNX stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

Based on aggregate information from My MarketBeat watchlists, some other companies that NovAccess Global investors own include Co-Diagnostics (CODX), iBio (IBIO), Onconova Therapeutics (ONTX), Tonix Pharmaceuticals (TNXP), T2 Biosystems (TTOO), Kopin (KOPN) and Adamis Pharmaceuticals (ADMP).

Company Calendar

Today
11/24/2024
Fiscal Year End
9/30/2025

Industry, Sector and Symbol

Sector
Medical
Industry
Pharmaceutical preparations
Sub-Industry
Pharmaceutical Products
Current Symbol
OTCMKTS:XSNX
Employees
3
Year Founded
N/A

Profitability

Net Income
$-4,720,000.00
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A
Book Value
($0.58) per share

Miscellaneous

Free Float
43,961,000
Market Cap
$401,400.00
Optionable
Not Optionable
Beta
1.89
Unlock the Potential in Options Trading Cover

Options trading isn’t just for the Wall Street elite; it’s an accessible strategy for anyone armed with the proper knowledge. Think of options as a strategic toolkit, with each tool designed for a specific financial task. Keep reading to learn how options trading can help you use the market’s volatility to your advantage.

Get This Free Report

This page (OTCMKTS:XSNX) was last updated on 11/24/2024 by MarketBeat.com Staff
From Our Partners